CV Directions Vol. 2, No. 1 | Page 6

ACE REACCREDITATION Q. What are the potential consequences of poor documentation? “ ACE reviewers provided guidance and a framework for standardizing our cath lab reporting system and improving our documentation. Poor cath lab documentation [can lead to] being misclassified by payers as a ‘high-cost provider.’” Ms. Reed: From the business development perspective, the biggest risks of poor documentation in the cath lab include being misclassified by payers as a “high-cost provider” or being misunderstood as having high complication rates. One example of how this can happen relates to the correct documentation of renal insufficiency versus renal failure following catheter-based procedures. The immediate impact of incorrect documentation is financial, as reimbursement rates for managing the same event in the same patient may differ substantially depending on whether it is coded as renal insufficiency or renal failure. The real difference, however, is how coding the same event will affect quality metrics. From a safety perspective, the Centers for Medicare and Medicaid Services (CMS) considers renal failure to be a complication of cardiovascular procedures. Each documented episode of renal failure contributes to the complication rate for the facility. Therefore, if an event is going to be documented as renal failure, it is critically important that it meets a welldefined threshold of clinical severity. In the near future, cath labs with poor documentation habits may run into trouble as payers increasingly embrace performance -based reimbursement models. We’ve seen a trend where payers are quick o adjust their internal benchmarks to align with new guideline recommendations each time the ACC/ AHA/SCAI clinical guidelines are updated. Right now, the question of whether payers will adopt AUC standards is an area of controversy and concern for many in the field. We are not at all worried about how this will play out, because we are already on that journey. Personally, I believe public and commercial payers are going to adopt AUC and other quality measures that tie reimbursement to performance. As a result of the ACE review process, we are already implementing the highest standard for documentation, and we will be prepared to demonstrate how our procedures meet the AUC for coronary revascularization and diagnostic catheterization. Q. How would you talk to payers about the value of ACE accreditation? Ms. Reed: We are vocal about the fact that we are ACE accredited, and we invite payers to look at the accreditation require- 6